Read more about provider contracting
Hi-Tech Contracting
Technology is an important factor in effecting successful contractual relationships between insurers and providers, but mostly from an administrative viewpoint. The Trizetto Group, a healthcare information technology company headquartered in Newport Beach, Calif., makes contracting easier with its NetworX Modeler and NetworX Pricer. Based on a plan's historical claims data, the Modeler presents potential financial impacts of varying contractual terms, and helps make comparisons between the cost of procedures by different providers.
Jeff Hensley, chief technology officer for Trizetto, believes, however, that episodic discounting rather than contracting based on procedures will lead to incentivizing providers to do the best job possible, rather than providing incentives to overutilize and overprescribe.
He considers the NetworX Modeler to be a good negotiating tool and if reimbursement methodologies change, he says can still see the financial impact and knows exactly to what he is agreeing.
The more predictability with price, the better, McIntire says, enabling WellPoint to promote its strategy of long-term contracts. "These contracts assure providers that they will remain in the network and assure members that their providers will be available, while avoiding the risk that a competitor will negotiate a better rate."
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
FDA Lifts Safety Restrictions on CAR T Therapies After Reviewing Real-World Data
July 2nd 2025FDA officials have determined that information regarding the risks for six CAR T-cell therapies can be communicated through product labeling, which includes a boxed warning for the risks of cytokine release syndrome and neurological toxicities.
Read More